Glembatumumab

MedChem Express

Glembatumumab

10

Research Use Only

Monoclonal

99.69

Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling ( ADC ) with antitumor activity [1] .

-80°C

12352203